399 related articles for article (PubMed ID: 22327827)
1. Skin bleeding time for the evaluation of uremic platelet dysfunction and effect of dialysis.
Soyoral YU; Demir C; Begenik H; Esen R; Kucukoglu ME; Aldemir MN; Demirkiran D; Erkoc R
Clin Appl Thromb Hemost; 2012; 18(2):185-8. PubMed ID: 22327827
[TBL] [Abstract][Full Text] [Related]
2. The effect of uremia on platelet contractile force, clot elastic modulus and bleeding time in hemodialysis patients.
Brophy DF; Martin EJ; Carr SL; Kirschbaum B; Carr ME
Thromb Res; 2007; 119(6):723-9. PubMed ID: 16793120
[TBL] [Abstract][Full Text] [Related]
3. Platelet dysfunction and end-stage renal disease.
Kaw D; Malhotra D
Semin Dial; 2006; 19(4):317-22. PubMed ID: 16893410
[TBL] [Abstract][Full Text] [Related]
4. The effect of recombinant human erythropoietin on hemostatic status in chronic uremic patients.
Tsao CJ; Kao RH; Cheng TY; Huang CC; Chang SL; Lee FN
Int J Hematol; 1992 Apr; 55(2):197-203. PubMed ID: 1511168
[TBL] [Abstract][Full Text] [Related]
5. [Case of uremic platelet dysfunction].
Ohzeki M; Fukushima T; Arakawa S; Ozeki M; Kosaka Y; Kobayashi S; Namikoshi T; Haruna Y; Sasaki T; Kashihara N
Nihon Jinzo Gakkai Shi; 2005; 47(7):834-8. PubMed ID: 16296414
[TBL] [Abstract][Full Text] [Related]
6. [Modification of uremic thrombocytopathy by hemodialysis].
Frick U; Frick G; Vitu J; Wiedenhöft I
Folia Haematol Int Mag Klin Morphol Blutforsch; 1983; 110(2):309-13. PubMed ID: 6194064
[TBL] [Abstract][Full Text] [Related]
7. Desmopressin improves platelet dysfunction measured by in vitro closure time in uremic patients.
Lee HK; Kim YJ; Jeong JU; Park JS; Chi HS; Kim SB
Nephron Clin Pract; 2010; 114(4):c248-52. PubMed ID: 20090366
[TBL] [Abstract][Full Text] [Related]
8. Phagocytic polymorphonuclear function in patients with progressive uremia and the effect of acute hemodialysis.
Mahajan S; Kalra OP; Asit KT; Ahuja G; Kalra V
Ren Fail; 2005; 27(4):357-60. PubMed ID: 16060119
[TBL] [Abstract][Full Text] [Related]
9. [Evaluation of platelet hemostasis in patients with chronic renal failure].
Krawczyk W; Dmoszyńska A; Sokołowska B
Wiad Lek; 1994 Feb; 47(3-4):93-9. PubMed ID: 7975649
[TBL] [Abstract][Full Text] [Related]
10. Role of platelet surface receptor abnormalities in the bleeding and thrombotic diathesis of uremic patients on hemodialysis and peritoneal dialysis.
Salvati F; Liani M
Int J Artif Organs; 2001 Mar; 24(3):131-5. PubMed ID: 11314805
[TBL] [Abstract][Full Text] [Related]
11. Desmopressin improves platelet function in uremic patients taking antiplatelet agents who require emergent invasive procedures.
Kim JH; Baek CH; Min JY; Kim JS; Kim SB; Kim H
Ann Hematol; 2015 Sep; 94(9):1457-61. PubMed ID: 25933676
[TBL] [Abstract][Full Text] [Related]
12. Dialyzable uremic solutes contribute to enhanced oxidation of serum albumin in regular hemodialysis patients.
Terawaki H; Nakayama K; Matsuyama Y; Nakayama M; Sato T; Hosoya T; Era S; Ito S
Blood Purif; 2007; 25(3):274-9. PubMed ID: 17460395
[TBL] [Abstract][Full Text] [Related]
13. Hemodialysis shortens long in vitro closure times as measured by the PFA-100.
Bilgin AU; Karadogan I; Artac M; Kizilors A; Bligin R; Undar L
Med Sci Monit; 2007 Mar; 13(3):CR141-5. PubMed ID: 17325638
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of acquired platelet dysfunctions in uremic and cirrhotic patients using the platelet function analyzer (PFA-100 ): influence of hematocrit elevation.
Escolar G; Cases A; Viñas M; Pino M; Calls J; Cirera I; Ordinas A
Haematologica; 1999 Jul; 84(7):614-9. PubMed ID: 10406903
[TBL] [Abstract][Full Text] [Related]
15. Platelet factor 3 in normal subjects and patients with renal failure.
Rabiner SF; Hrodek O
J Clin Invest; 1968 Apr; 47(4):901-12. PubMed ID: 5641625
[TBL] [Abstract][Full Text] [Related]
16. [The risk of bleeding associated with low molecular weight heparin in patients with renal failure].
Lai S; Barbano B; Cianci R; Gigante A; Di Donato D; Asllanaj B; Dimko M; Mariotti A; Morabito S; Pugliese F
G Ital Nefrol; 2010; 27(6):649-54. PubMed ID: 21132647
[TBL] [Abstract][Full Text] [Related]
17. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
18. [Effects of the treatment with human recombinant erythropoietin on primary hemostasis in uremic patients].
Cases A; Escolar G; Reverter JC; Garrido M; Ordinas A; López-Pedret J; Castillo R; Revert L
Med Clin (Barc); 1990 Nov; 95(17):644-7. PubMed ID: 2089202
[TBL] [Abstract][Full Text] [Related]
19. Gastro-duodenal lesions and Helicobacter pylori infection in uremic patients and renal transplant recipients.
Khedmat H; Ahmadzad-Asl M; Amini M; Lessan-Pezeshki M; Einollahi B; Pourfarziani V; Naseri MH; Davoudi F
Transplant Proc; 2007 May; 39(4):1003-7. PubMed ID: 17524875
[TBL] [Abstract][Full Text] [Related]
20. Effect of hemodialysis on platelet function in end-stage renal disease Egyptian patients using in vitro closure time test (PFA-100 analyzer).
Mekawy MA; Habashy DM; Abd El-Mohsen WA
Platelets; 2015; 26(5):443-7. PubMed ID: 24955720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
